Tandem Diabetes Care, Inc. (TNDM)Healthcare | Medical Devices | San Diego, United States | NasdaqGM
20.61 USD
+0.52
(2.588%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 20.66 +0.05 (0.240%) ⇧ (April 17, 2026, 5:48 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:02 a.m. EDT
Tandem Diabetes (TNDM) represents a classic 'value trap' story masked by analyst upgrades; while Q4 revenue beat and the new monetization model provide necessary top-line clarity, the company remains deeply unprofitable with -20% profit margins and -53% return on assets. The technical structure is fragile, trading below its 50-day moving average with significant downward pressure. While the lack of options positioning suggests a lack of immediate downside threats, the absence of a clear fundamental pivot point keeps the long-term case speculative. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.100845 |
| AutoARIMA | 0.101327 |
| AutoETS | 0.101327 |
| AutoTheta | 0.101979 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 80% |
| H-stat | 0.55 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.106 |
| Excess Kurtosis | -0.89 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 289.602 |
| Revenue per Share | 15.081 |
| Market Cap | 1,411,872,256 |
| Forward P/E | -872.57 |
| Beta | 1.74 |
| Profit Margins | -20.17% |
| Website | https://www.tandemdiabetes.com |
As of April 19, 2026, 12:02 a.m. EDT: Options speculators exhibit high uncertainty and a balanced risk-off posture. Implied Volatility (IV) is extremely low across near-term expirations (<0.10), indicating a lack of conviction in significant moves. Notable flow appears in long-dated 2027 puts (high IV at ~20.0 strike) and vol-atm premiums (high IV at ~20.09 strike) for nearly 50% terminal expiry, suggesting traders are positioning for a potential long-term bottom or liquidity event rather than immediate directional bias. Intraday skewing suggests neutral pricing of the short-term volatility despite mixed positioning at the money.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.25747406 |
| Address1 | 12,400 High Bluff Drive |
| All Time High | 302.5 |
| All Time Low | 2.14 |
| Ask | 20.86 |
| Ask Size | 13 |
| Audit Risk | 3 |
| Average Analyst Rating | 2.1 - Buy |
| Average Daily Volume10 Day | 1,532,850 |
| Average Daily Volume3 Month | 2,041,111 |
| Average Volume | 2,041,111 |
| Average Volume10Days | 1,532,850 |
| Beta | 1.743 |
| Bid | 20.46 |
| Bid Size | 13 |
| Board Risk | 2 |
| Book Value | 2.272 |
| City | San Diego |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 5 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 20.61 |
| Current Ratio | 2.547 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 21.3225 |
| Day Low | 20.355 |
| Debt To Equity | 289.602 |
| Display Name | Tandem Diabetes Care |
| Dividend Date | 1,507,593,600 |
| Earnings Call Timestamp End | 1,778,185,800 |
| Earnings Call Timestamp Start | 1,778,185,800 |
| Earnings Timestamp | 1,778,184,000 |
| Earnings Timestamp End | 1,778,184,000 |
| Earnings Timestamp Start | 1,778,184,000 |
| Ebitda | -60,456,000 |
| Ebitda Margins | -0.059580002 |
| Enterprise To Ebitda | -25.885 |
| Enterprise To Revenue | 1.542 |
| Enterprise Value | 1,564,906,368 |
| Eps Current Year | -0.7956 |
| Eps Forward | -0.02362 |
| Eps Trailing Twelve Months | -3.04 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 21.6442 |
| Fifty Day Average Change | -1.0341988 |
| Fifty Day Average Change Percent | -0.0477818 |
| Fifty Two Week Change Percent | 25.747406 |
| Fifty Two Week High | 29.65 |
| Fifty Two Week High Change | -9.039999 |
| Fifty Two Week High Change Percent | -0.30489036 |
| Fifty Two Week Low | 9.98 |
| Fifty Two Week Low Change | 10.630001 |
| Fifty Two Week Low Change Percent | 1.0651305 |
| Fifty Two Week Range | 9.98 - 29.65 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,384,439,400,000 |
| Float Shares | 62,606,364 |
| Forward Eps | -0.02362 |
| Forward P E | -872.5657 |
| Free Cashflow | -44,731,124 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 2,500 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.53808 |
| Gross Profits | 546,014,016 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00749 |
| Held Percent Institutions | 1.12305 |
| Implied Shares Outstanding | 68,504,233 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,507,593,600 |
| Last Split Factor | 1:10 |
| Long Business Summary | Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California. |
| Long Name | Tandem Diabetes Care, Inc. |
| Market | us_market |
| Market Cap | 1,411,872,256 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_46368713 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -204,710,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,412,557,284 |
| Number Of Analyst Opinions | 21 |
| Open | 20.68 |
| Operating Cashflow | -9,721,000 |
| Operating Margins | 0.02856 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Phone | 858 366 6900 |
| Post Market Change | 0.04940033 |
| Post Market Change Percent | 0.23969106 |
| Post Market Price | 20.6594 |
| Post Market Time | 1,776,462,488 |
| Previous Close | 20.09 |
| Price Eps Current Year | -25.904978 |
| Price Hint | 2 |
| Price To Book | 9.071302 |
| Price To Sales Trailing12 Months | 1.391369 |
| Profit Margins | -0.20174 |
| Quick Ratio | 1.888 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.08696 |
| Region | US |
| Regular Market Change | 0.52 |
| Regular Market Change Percent | 2.58835 |
| Regular Market Day High | 21.3225 |
| Regular Market Day Low | 20.355 |
| Regular Market Day Range | 20.355 - 21.3225 |
| Regular Market Open | 20.68 |
| Regular Market Previous Close | 20.09 |
| Regular Market Price | 20.61 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 1,968,355 |
| Return On Assets | -0.05282 |
| Return On Equity | -0.97885 |
| Revenue Growth | 0.027 |
| Revenue Per Share | 15.081 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 68,504,233 |
| Shares Percent Shares Out | 0.1537 |
| Shares Short | 10,531,890 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 9,763,559 |
| Short Name | Tandem Diabetes Care, Inc. |
| Short Percent Of Float | 0.207 |
| Short Ratio | 5.38 |
| Source Interval | 15 |
| State | CA |
| Symbol | TNDM |
| Target High Price | 56.0 |
| Target Low Price | 20.0 |
| Target Mean Price | 30.61905 |
| Target Median Price | 29.0 |
| Total Cash | 292,665,984 |
| Total Cash Per Share | 4.283 |
| Total Debt | 449,375,008 |
| Total Revenue | 1,014,736,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.04 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 17.82575 |
| Two Hundred Day Average Change | 2.7842503 |
| Two Hundred Day Average Change Percent | 0.1561926 |
| Type Disp | Equity |
| Volume | 1,968,355 |
| Website | https://www.tandemdiabetes.com |
| Zip | 92,130 |